Nancy Mc Kinstry is Director of Accenture plc. Currently has a direct ownership of 6,855 shares of ACN, which is worth approximately $2.45 Million. The most recent transaction as insider was on Nov 15, 2024, when has been sold 4 shares (Class A Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.86K
0.06% 3M change
4.96% 12M change
Total Value Held $2.45 Million

Nancy McKinstry Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 15 2024
BUY
Grant, award, or other acquisition
-
4 Added 0.06%
6,855 Class A Ordinary Shares
Aug 15 2024
BUY
Grant, award, or other acquisition
-
4 Added 0.06%
6,851 Class A Ordinary Shares
May 15 2024
BUY
Grant, award, or other acquisition
-
4 Added 0.06%
6,847 Class A Ordinary Shares
Feb 15 2024
SELL
Payment of exercise price or tax liability
$744 $372.35 p/Share
2 Reduced 0.03%
6,843 Class A Ordinary Shares
Feb 15 2024
BUY
Grant, award, or other acquisition
-
4 Added 0.06%
6,845 Class A Ordinary Shares
Feb 01 2024
SELL
Payment of exercise price or tax liability
$201,664 $367.33 p/Share
549 Reduced 7.43%
6,841 Class A Ordinary Shares
Jan 31 2024
BUY
Grant, award, or other acquisition
-
859 Added 10.41%
7,390 Class A Ordinary Shares
Nov 15 2023
BUY
Grant, award, or other acquisition
-
5 Added 0.08%
6,531 Class A Ordinary Shares
Aug 15 2023
BUY
Grant, award, or other acquisition
-
5 Added 0.08%
6,526 Class A Ordinary Shares
May 15 2023
BUY
Grant, award, or other acquisition
-
5 Added 0.08%
6,521 Class A Ordinary Shares
Feb 15 2023
SELL
Payment of exercise price or tax liability
$569 $284.9 p/Share
2 Reduced 0.03%
6,516 Class A Ordinary Shares
Feb 15 2023
BUY
Grant, award, or other acquisition
-
4 Added 0.06%
6,518 Class A Ordinary Shares
Feb 01 2023
BUY
Grant, award, or other acquisition
-
1,127 Added 14.75%
6,514 Class A Ordinary Shares
Jan 26 2023
SELL
Payment of exercise price or tax liability
$109,640 $274.1 p/Share
400 Reduced 6.91%
5,387 Class A Ordinary Shares
Nov 15 2022
BUY
Grant, award, or other acquisition
-
4 Added 0.07%
5,787 Class A Ordinary Shares
Aug 15 2022
BUY
Grant, award, or other acquisition
-
3 Added 0.05%
5,783 Class A Ordinary Shares
May 13 2022
BUY
Grant, award, or other acquisition
-
4 Added 0.07%
5,780 Class A Ordinary Shares
Feb 15 2022
SELL
Payment of exercise price or tax liability
$661 $330.34 p/Share
2 Reduced 0.03%
5,776 Class A Ordinary Shares
Feb 15 2022
BUY
Grant, award, or other acquisition
-
4 Added 0.07%
5,778 Class A Ordinary Shares
Feb 03 2022
SELL
Payment of exercise price or tax liability
$196,940 $347.95 p/Share
566 Reduced 8.93%
5,774 Class A Ordinary Shares
Jan 26 2022
BUY
Grant, award, or other acquisition
-
911 Added 12.56%
6,340 Class A Ordinary Shares
Nov 15 2021
BUY
Grant, award, or other acquisition
-
4 Added 0.07%
5,429 Class A Ordinary Shares
Aug 13 2021
BUY
Grant, award, or other acquisition
-
4 Added 0.07%
5,425 Class A Ordinary Shares
May 14 2021
BUY
Grant, award, or other acquisition
-
4 Added 0.07%
5,421 Class A Ordinary Shares
Feb 12 2021
SELL
Payment of exercise price or tax liability
$514 $257.0 p/Share
2 Reduced 0.04%
5,417 Class A Ordinary Shares

Also insider at

ABT
ABBOTT LABORATORIES Healthcare
NM

Nancy Mc Kinstry

Director
Chicago, IL

Track Institutional and Insider Activities on ACN

Follow Accenture plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACN shares.

Notify only if

Insider Trading

Get notified when an Accenture PLC insider buys or sells ACN shares.

Notify only if

News

Receive news related to Accenture plc

Track Activities on ACN